Summary
The Nandrolone Phenylpropionate Raw Powder, used by Stanford Pharmaceuticals to develop its corresponding injectable product, underwent independent testing to verify its composition and potency. The sample was submitted by Stanford Pharmaceuticals and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis confirmed the presence of Nandrolone Phenylpropionate, with a measured purity of 96%+.
The testing process began on 29 April 2024, with the sample received on 17 May 2024, and analysis completed on 21 May 2024. While the results confirm the presence of Nandrolone Phenylpropionate, scrutiny of manufacturer-submitted samples remains essential to ensure consistency. Independent third-party testing is crucial to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Stanford Pharmaceuticals
- Product Name: A Sample
- Active Ingredient: Nandrolone Phenylpropionate
- Batch Number: Not Provided
- Expiration Date: Not Provided
- Delivery Method: Viral Powder
Sample Acquisition and Testing
- Task Number: #42432
- Testing Ordered: 29 April 2024
- Sample Received: 17 May 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Stanford Pharmaceuticals (Manufacturer)
- Analysis Paid For By: Stanford Pharmaceuticals (Manufacturer)
Testing Results
- Compound Detected: Nandrolone Phenylpropionate
- Purity: 96%+
Verification Details
Verification URL: https://janoshik.com/tests/42432_AJ28R9LTX37L
Evaluation of Manufacturer-Submitted Testing
This analysis confirms the presence of Nandrolone Phenylpropionate in the tested sample with a measured purity of 96%+. However, since Stanford Pharmaceuticals submitted and funded the test, careful evaluation is needed to assess product consistency across different batches. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple samples.
Conclusion
The analysis confirms that the A Sample contains Nandrolone Phenylpropionate with a purity of 96%+. While this batch meets expected quality parameters, the absence of batch details and independent verification highlights the need for further third-party testing to ensure consistency across production. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding anabolic steroid-based products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
